摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-Dichloroquinazolin-4-amine | 944895-55-0

中文名称
——
中文别名
——
英文名称
2,6-Dichloroquinazolin-4-amine
英文别名
——
2,6-Dichloroquinazolin-4-amine化学式
CAS
944895-55-0
化学式
C8H5Cl2N3
mdl
——
分子量
214.054
InChiKey
SQYVXXSSMNSOCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-甲基哌嗪2,6-Dichloroquinazolin-4-amine甲醇 为溶剂, 反应 0.08h, 生成 VUF 10351
    参考文献:
    名称:
    Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
    摘要:
    与组织胺H4受体相互作用的化合物,可能用于治疗或预防由组织胺H4受体介导的疾病和症状,如炎症,其化学式为(I),其中Q为CR1或N;X为CR2或N,前提是Q和X不同时为N;Y为CR3或N;Z为CH或N;R1、R2、R3、R4、R5和R6独立地为H、F、Cl、Br、I或可选择含有一个或多个杂原子的碳氢基团;R7为包含一个或多个N原子的杂环基团;或其药用盐、酯或溶剂化合物。
    公开号:
    US20100016293A1
  • 作为产物:
    描述:
    2,4,6-三氯喹唑啉 作用下, 以 甲醇 为溶剂, 反应 16.0h, 生成 2,6-Dichloroquinazolin-4-amine
    参考文献:
    名称:
    Discovery of Quinazolines as Histamine H4 Receptor Inverse Agonists Using a Scaffold Hopping Approach
    摘要:
    From a series of small fragments that was designed to probe the histamine H-4 receptor (H4R), we previously described quinoxaline-containing fragments that were grown into high affinity H4R ligands in a process that was guided by pharmacophore modeling. With a scaffold hopping exercise and using the same in silico models, we now report the identification and optimization of a series of quinazoline-containing H4R compounds. This approach led to the discovery of 6-chloi-o-N-(furan-3-yl)methyl)2-(4-methylpiperzin-1-yl)quinazolin-4-amine (VUF10499, 54) and 6-chloro-2-(4-methylpiperazin-1-yl)-N-(thiophen-2-ylmethyl)quinazolin-4-amine (VUF10497, 55) as potent human H4R inverse agonists (pK(i) = 8.12 and 7.57, respectively). Interestingly, both compounds also possess considerable affinity for the human histamine Hi receptor (H1R) and therefore represent a novel class of dual action H1R/H4R ligands, a profile that potentially leads to added therapeutic benefit. Compounds from this novel series of quirlazolines are antagonists at the rat H4R and were found to possess anti-inflammatory properties in vivo in the rat.
    DOI:
    10.1021/jm800876b
点击查看最新优质反应信息

文献信息

  • [EN] BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS<br/>[FR] MODULATEURS ALLOSTÉRIQUES DE RÉCEPTEURS BÊTA-ADRÉNERGIQUES
    申请人:UNIV CALIFORNIA
    公开号:WO2019204768A1
    公开(公告)日:2019-10-24
    Provided herein are modulators of beta-adrenergic receptors.
    这里提供了β肾上腺素受体的调节剂。
  • Design, Synthesis, and Structure–Activity Relationships of Highly Potent 5-HT<sub>3</sub> Receptor Ligands
    作者:Mark H. P. Verheij、Andrew J. Thompson、Jacqueline E. van Muijlwijk-Koezen、Sarah C. R. Lummis、Rob Leurs、Iwan J. P. de Esch
    DOI:10.1021/jm300801u
    日期:2012.10.25
    The 5-HT3 receptor, a pentameric ligand-gated ion channel (pLGIC), is an important therapeutic target. During a recent fragment screen, 6-chloro-N-methyl-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine (1) was identified as a 5-HT3R hit fragment. Here we describe the synthesis and structure activity relationships (SAR) of a series of (iso)quinoline and quinazoline compounds that were synthesized and screened for 5-HT3R affinity using a [H-3]granisetron displacement assay. These studies resulted in the discovery of several high affinity ligands of which compound 22 showed the highest affinity (pK(i) > 10) for the 5-HT3 receptor. The observed SAR is in agreement with established pharmacophore models for 5-HT3 ligands and is used for ligand-receptor binding mode prediction using homology modeling and in silico docking approaches.
  • BETA-ADRENERGIC RECEPTOR ALLOSTERIC MODULATORS
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20210353626A1
    公开(公告)日:2021-11-18
    Provided herein are modulators of beta-adrenergic receptors.
查看更多